George "Trip" Zorn III, MD

Medical School, University of Alabama, Birmingham, Alabama
Residency, Vanderbilt University Medical Center, Nashville, Tennessee
Fellowship, University of Virginia, Charlottesville, Virginia (Cardiothoracic Surgery)

Clinical Interests

  • Cardiac Valve Repair
  • Heart Valve Surgery
  • Aortic Aneurysm
  • Thoracic Aneurysm Surgery
  • Lung Cancer Surgery
  • Heart Rhythm Problems
  • Cardiac Valve Replacement
  • Coronary Artery Disease Surgery
  • Cardiothoracic Surgery
  • Cardiovascular Surgery
  • Hypertrophic Cardiomyopathy
  • Thoracic Surgery

Research Interests

  • Heart Rhythm Problems
  • Aneurysm Repair
  • Cardiac Valve Replacement
  • Cardiovascular Surgery
  • Hypertrophic Cardiomyopathy

Research Projects
Active projects

A registry of patients with descending thoracic aortic aneurysm treated with the GORE TAG Thoracic Endoprosthesis, sponsored by W.L. Gore & Associates.

A registry of patients undergoing aortic valve replacement using the ATS 3f® Aortic Bioprosthesis Model 1000 Valve, sponsored by ATS Medical.

A study of patients with acute Type B aortic dissection treated with the GORE Conformable TAG® Thoracic Endoprosthesis, sponsored by W.L. Gore & Associates.


  • Suzanne Arnold; Matthew Reynolds; Kaijun Wang; Elizabeth Magnuson; Suzanne Baron; Khaja Chinnakondepalli; Michael Reardon; Peter Tadros; George Zorn; Brijeshwar Maini; Mubashir Mumtaz; John Brown; Robert Kipperman; David Adams; Jeffrey Popma; David Cohen. Health status after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the corevalve us pivotal trial. J Am Coll Cardiol. 2015;65(10_S):.  doi:10.1016/S0735-1097(15)61999-4.



Last modified: May 08, 2015

George “Trip” Zorn III, MD


George "Trip" Zorn III, MD